Skip to main content

Peer Review reports

From: SAVER: sodium valproate for the epigenetic reprogramming of high-risk oral epithelial dysplasia—a phase II randomised control trial study protocol

Original Submission
10 Mar 2021 Submitted Original manuscript
14 Jun 2021 Reviewed Reviewer Report - Claire Cochran
Resubmission - Version 2
Submitted Manuscript version 2
15 Jun 2021 Editorially accepted
5 Jul 2021 Article published 10.1186/s13063-021-05373-8

You can find further information about peer review here.

Back to article page